# Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

> **NCT02849171** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Brain Cancer

## Interventions

- **DEVICE:** PET scan
- **RADIATION:** C-Choline

## Key facts

- **NCT ID:** NCT02849171
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2022-05-06
- **Final completion:** 2022-05-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849171, "Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02849171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*